Research Highlights Lysozyme Based Oral Care Support During Cancer Therapy

A recent 2025 scientific publication explored the potential benefits of lysozyme based oral care approaches for patients undergoing radiotherapy treatment for head and neck cancers. The research focused on radiotherapy induced oral mucositis, a common condition associated with oral discomfort, inflammation, and difficulty eating during cancer treatment.

Oral mucositis, a common challenge in oncology patients, particularly those with head and neck cancer, is characterized by ulcerative inflammatory changes in the oral mucosa. Treatment focuses on tissue regeneration, immunomodulation, antimicrobial activity, and pain management, with palifermin being the only approved drug. Despite its impact on quality of life and treatment success, prevention and treatment options remain limited.

Researchers evaluated a lysozyme based oral spray and reported improvements in patient comfort along with reduced pain intensity during eating. The study also demonstrated favorable safety and tolerability throughout the treatment period. Scientists noted that lysozyme, a naturally occurring enzyme found in saliva, may help support sensitive oral tissues as part of modern oral care strategies. The growing scientific interest in naturally inspired oral care ingredients reflects the increasing focus on gentle, alcohol free, and microbiome conscious oral hygiene approaches for patients with sensitive oral conditions.

H2Ocean Healing Rinse Mouthwash combines lysozyme with mineral rich Red Sea salt containing over 82 naturally occurring trace minerals, creating a synergistic alcohol free oral care formulation. The combination of natural enzymes, sea minerals, and xylitol helps support oral comfort, oral hygiene, and tissue friendly care for chemo mouth during cancer therapy. This unique multi ingredient approach provides an enhanced oral care support system aligned with modern microbiome-conscious and naturally inspired oral wellness strategies.